The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•18 April 2026•

1 min read

Genmab Completes Share Capital Reduction via Cancellation of 1.9 Million Treasury Shares

Key Facts

1Genmab completed a share capital reduction of DKK 1,900,000 by cancelling 1,900,000 treasury shares.

2The decision was approved at the Company's Annual General Meeting on March 19, 2026.

Genmab A/S has officially finalized a share capital reduction of DKK 1,900,000 through the cancellation of 1,900,000 treasury shares. The corporate action was formally registered with the Danish Business Authority following approval at the company's Annual General Meeting held on March 19, 2026. This strategic move is designed to optimize the company's capital structure and return value to its shareholders. By reducing the total number of outstanding shares, the company expects to see a positive impact on earnings per share (EPS). Genmab, which trades under the tickers GMAB and GEN.CO, continues to demonstrate a commitment to disciplined capital management. Investors typically view such cancellations as a bullish signal for long-term equity valuation.